what backs up cryptocurrency Top Knowledge graph

Huabei Pharmaceutical Co., Ltd.: Four kinds of drugs under the company are planned to be selected for national centralized drug procurement. Huabei Pharmaceutical announced that the company and its subsidiary Xiantai Company participated in the tenth batch of national centralized drug procurement, and all four varieties are planned to be selected, including penicillin sodium for injection, piperacillin sodium for injection, ampicillin sodium for injection and sulbactam sodium for injection. The price of the drug to be selected this time has decreased compared with the original sales price. In 2023, the sales income of penicillin sodium for injection was 129 million yuan, accounting for 1.28% of the annual operating income. If the bid is confirmed and the purchase and sale contract is signed, the company will fully guarantee the supply according to the demand of the selected area, and promote the increment of related products in the selected area and the development of the off-standard market.Market News: Turkish anti-monopoly agency fined Google $75 million for advertising technology investigation.Domestic futures opened mixed at night, with Shanghai Gold down 0.57%, Shanghai Silver down more than 1%, Shanghai Zinc up 0.68%, thread down 0.5%, coking coal down 0.6%, glass down 1.22% and crude oil up nearly 1%.

Bei Ya raised Broadcom's target price from $195.00 to $210.00.BYD Lian Yubo: It is estimated that BYD will sell 4.25 million vehicles in the whole year. On December 13th, BYD's chief scientist Lian Yubo said: "Up to now, BYD has sold more than 10 million new energy vehicles. By the end of this month, we can probably achieve the annual sales of 4.25 million vehicles. " He also mentioned: "There are still some challenges in industrial development. For example, the overall anti-risk ability of our industrial chain needs to be improved, and there are still breakthroughs in chips, operating technologies, industrial software and nuclear materials. We still need to strengthen research and achieve complete autonomy and controllability."Market News: Austria provides 1,000 euros to Syrian refugees to help them return home.

Senior EU officials: The foreign ministers of 27 EU countries will approve the 15th round of sanctions against Russia and new sanctions "against hybrid operations" on December 16th.Bayrou was appointed as the new Prime Minister of France. French public opinion regards him as a staunch political ally of Macron. The Elysee Palace, the French presidential palace, announced on the 13th that President Macron appointed francois bayrou, chairman of the Democratic Movement Party, as the new Prime Minister on the same day, replacing Banier, who resigned after being impeached by the National Assembly. According to French media reports, Macron had a telephone conversation with Bayrou on the evening of 12th, and on the morning of 13th, Macron met Bayrou in the presidential palace and talked again. Macron subsequently announced the appointment decision. Bayrou became the fourth French prime minister this year. Beru founded the Democratic Movement Party, a centrist party, in 2007, and has served as its chairman ever since. In 2017, Bayrou announced that he would give up running for the French president, and formed an alliance with Macron, one of the popular candidates in the presidential election at that time and the chairman of the "Forward" movement, to fully support Macron's presidential election. In 2022, in the process of Macron's re-election, Bayrou led the Democratic Movement Party to continue to form an alliance with the ruling party. French public opinion regards Bayrou as a staunch political ally of Macron. (Xinhua News Agency)Huabei Pharmaceutical Co., Ltd.: Four kinds of drugs under the company are planned to be selected for national centralized drug procurement. Huabei Pharmaceutical announced that the company and its subsidiary Xiantai Company participated in the tenth batch of national centralized drug procurement, and all four varieties are planned to be selected, including penicillin sodium for injection, piperacillin sodium for injection, ampicillin sodium for injection and sulbactam sodium for injection. The price of the drug to be selected this time has decreased compared with the original sales price. In 2023, the sales income of penicillin sodium for injection was 129 million yuan, accounting for 1.28% of the annual operating income. If the bid is confirmed and the purchase and sale contract is signed, the company will fully guarantee the supply according to the demand of the selected area, and promote the increment of related products in the selected area and the development of the off-standard market.